Introduction

Pakistan’s biotech and life sciences sector is rich in research but struggles with commercialization. Universities and R&D institutes often lack the frameworks to translate breakthroughs into marketable products—a gap AIK addresses through innovation advisory and ecosystem development.

Critical Barriers

    • Funding Shortages: Aligning projects with investor priorities.

    • Regulatory Hurdles: Navigating compliance for medical devices/drugs.

    • Supply Chain Gaps: Localizing raw materials to cut import dependence.

AIK’s Approach

  • Drawing on our founder’s experience at IBGE, we:

    1. Design Roadmaps: Prioritize projects with high scalability.

    2. Facilitate Partnerships: Connect labs with manufacturers and policymakers.

    3. Pilot Testing: Validate feasibility before full-scale production.

Example Initiative

  • We’re currently partnering with a national institute to launch a biomedical incubator, accelerating startups in diagnostic devices.

    Call to Action
    Turn your research into impact. Reach out for a commercialization strategy session.